Common Stock, Shares, Outstanding of Q32 Bio Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Q32 Bio Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Q32 Bio Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 12,858,047, a 5.4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Q32 Bio Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 12,858,047 +660,432 +5.4% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q3 2025 12,304,352 +165,483 +1.4% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 12,197,615 +202,409 +1.7% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 12,197,615 +268,095 +2.2% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 12,197,615 +11,838,046 +3292% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 12,138,869 -45,763,341 -79% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 11,995,206 -45,802,927 -79% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 11,929,520 -45,865,247 -79% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 359,569 -57,124,341 -99% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 57,902,210 +421,600 +0.73% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 57,798,133 +412,555 +0.72% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 57,794,767 +409,189 +0.71% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 57,483,910 +333,636 +0.58% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 57,480,610 +330,632 +0.58% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 57,385,578 +298,621 +0.52% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 57,385,578 +6,900,009 +14% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 57,150,274 +6,884,699 +14% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 57,149,978 +11,890,231 +26% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 57,086,957 +11,876,304 +26% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 50,485,569 +5,279,503 +12% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 50,265,575 +5,148,833 +11% 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q3 2020 45,259,747 +1,303,677 +3% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 45,210,653 +1,341,039 +3.1% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 45,206,066 +7,768,769 +21% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 45,116,742 +7,758,216 +21% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 43,956,070 +6,646,007 +18% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 43,869,614 +6,614,712 +18% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 37,437,297 +34,739,945 +1288% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 37,358,526 +34,721,515 +1317% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 37,310,063 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 37,254,902 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 2,697,352 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 2,637,011 31 Dec 2017 10-K 12 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.